Relypsa, Inc.
Overview
Relypsa, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of polymeric medicines. It is a subsidiary of Vifor Pharma and specializes in therapies for treating conditions related to kidney diseases.
Therapeutic areas
Kidney DiseasesElectrolyte Disorders
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Relypsa, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.